Talk to Gabby Chat Nevada
Connecting...

Loading chat history..

Something went wrong.Please try again later.

×
Powered by
×

Nevada Medicaid and Nevada Check Up News (Third Quarter 2024 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Notifications

Unwinding COVID-19 Information

Known System Issues-Click HERE

Paper claims are no longer accepted by Nevada Medicaid. Please refer to Web Announcement 1733 and Web Announcement 1829 for additional information.

Top 10 Claim Denial Reasons and Resolutions/Workarounds for November 2024 Professional Claims. See Web Announcement 3509.

Top Enrollment Return Reasons and Resolutions for January 2024 Submissions. See Web Announcement 3350.

Top Prior Authorization Denial Reasons for the Third Quarter of 2024. See Web Announcement 3488.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Notice Date Title
October 2017 For Review at October 19, 2017 Meeting: Dental Response for Tramadol and Codeine
October 2017 For Review at October 19, 2017 Meeting: Antiasthmatic – Monoclonal Antibodies
October 2017 For Review at October 19, 2017 Meeting: Austedo™ (Deutetrabenazine)
October 2017 For Review at October 19, 2017 Meeting: Brineura™ (Cerliponase Alfa)
October 2017 For Review at October 19, 2017 Meeting: Emflaza™ (Deflazacort)
October 2017 For Review at October 19, 2017 Meeting: Ingrezza™ (Valbenazine)
October 2017 For Review at October 19, 2017 Meeting: Xadago® (Safinamide)
July 2017 For Review at July 27, 2017 Meeting: Antiemetics - Delta-9-Tetrahydrocannabinol (THC) Derivatives
July 2017 For Review at July 27, 2017 Meeting: Immunomodulators
July 2017 For Review at July 27, 2017 Meeting: NSAID Gastroprotective Combination Agents and COX-2 Inhibitor
July 2017 For Review at July 27, 2017 Meeting: Opioids, Short Acting
July 2017 For Review at July 27, 2017 Meeting: Tramadol and Related Products
April 2017 For Review at April 27, 2017, Meeting: Atypical Antipsychotics
April 2017 For Review at April 27, 2017, Meeting: Exondys 51 (Agent for Duchenne Muscular Dystrophy)
April 2017 For Review at April 27, 2017, Meeting: Incretin Mimetics & Amylinomimetics
April 2017 For Review at April 27, 2017, Meeting: Spinraza (Nusinersen) (Agent for Spinal Muscular Atrophy)
January 2017 For Review at January 26, 2017, Meeting: Incretin Mimetics & Amylinomimetics
January 2017 For Review at January 26, 2017, Meeting: Lumacaftor/Ivacaftor (Orkambi®)
January 2017 For Review at January 26, 2017, Meeting: Opioid Partial Agonist for Management of Opioid Dependence (Buprenorphine)

Return to Past Meeting Materials.